86.22.Z - Specialist medical practice
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
72.11.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
86.21.Z - General medical practice
86.90.A - Healthcare
86.90.C - Healthcare
86.90.E - Healthcare
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,3 | -0,4 | 0 | 100 |
Gross profit (loss) | -0,3 | -0,4 | 0 | 108,9 |
EBITDA | -0,3 | -0,4 | 0 | 110,2 |
Short time liabilities | 1,7 | 1,9 | 1,9 | 0,5 |
Other operating costs | 0 | 0 | 0 | 142,6 |
Equity capital | -1,2 | -1,8 | -1,8 | 2,4 |
Operating profit (EBIT) | -0,3 | -0,4 | 0 | 110,1 |
Assets | 0,5 | 0,2 | 0,2 | -28,1 |
Net profit (loss) | -0,3 | -0,4 | 0 | 108,9 |
Cash | 0,1 | 0,1 | 0,2 | 21,3 |
Liabilities and provisions for liabilities | 1,8 | 2,1 | 2 | -5,4 |
Net income from sale | 2,4 | 0,4 | 0 | -100 |
Working assets | 0,5 | 0,2 | 0,2 | -24,2 |
Other income costs | 0 | 0 | 0,1 | 1700,9 |
Depreciation | 0 | 0 | 0 | -100 |
% | % | % | p.p. | |
Profitability of capital | 26 | 23 | -2,1 | -25,1 |
Equity capital to total assets | -226,7 | -743,4 | -1009,6 | -266,2 |
Gross profit margin | -13,6 | -99 | -85,4 | |
EBITDA Margin | -11,6 | -85,9 | -74,3 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 257 | 1635 | 2 147 483 648 | 2 147 482 013 |
Current financial liquidity indicator | 0.31276172399520874 | 0.12292962521314621 | 0.09263778477907181 | 0 |
Net dept to EBITDA | -4.669245719909668 | -3.502225399017334 | 33.43122863769531 | 36,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane